SILO PHARMA, INC. Interest Expense, Related Party
SILO PHARMA, INC. (SILO) reported Interest Expense, Related Party of $224 for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-28.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseRelatedParty · last filed 2022-03-28
- SILO PHARMA, INC. interest expense, related party for the quarter ending 2020-12-31 was $0.00.
- SILO PHARMA, INC. interest expense, related party for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- SILO PHARMA, INC. interest expense, related party for the quarter ending 2020-06-30 was $172.00.
- SILO PHARMA, INC. interest expense, related party for the quarter ending 2020-03-31 was $52.00.
- SILO PHARMA, INC. interest expense, related party for fiscal 2020 was $224.00, a 18.52% increase from fiscal 2019.
- SILO PHARMA, INC. interest expense, related party for fiscal 2019 was $189.00.
| Period end | Interest Expense, Related Party 3 month | Interest Expense, Related Party 6 month | Interest Expense, Related Party 9 month | Interest Expense, Related Party 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $0.00 derived: sum of 2 quarters · filed 2022-03-28 | $172.00 derived: sum of 3 quarters · filed 2022-03-28 | $224.00 10-K · filed 2022-03-28 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $172.00 derived: sum of 2 quarters · filed 2021-11-10 | $224.00 10-Q · filed 2021-11-10 | $38.00 derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $172.00 10-Q · filed 2021-08-13 | $224.00 10-Q · filed 2021-08-13 | $38.00 derived: sum of 3 quarters · filed 2021-08-13 | $413.00 derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $52.00 10-Q · filed 2021-05-17 | -$134.00 derived: sum of 2 quarters · filed 2021-05-17 | $241.00 derived: sum of 3 quarters · filed 2021-05-17 | |
| 2019-12-31 | -$186.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | $189.00 derived: sum of 2 quarters · filed 2021-05-17 | $189.00 10-K/A · filed 2021-05-17 | |
| 2019-09-30 | $375.00 10-Q · filed 2020-11-05 | $375.00 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |